- OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
- OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
- OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
- OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
- OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
- OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
- OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
- OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
- OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
More ▼
Key statistics
On Thursday, OrthoPediatrics Corp (KIDS:NMQ) closed at 33.49, 44.98% above the 52 week low of 23.10 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 33.16 |
---|---|
High | 34.02 |
Low | 33.12 |
Bid | 13.40 |
Offer | 35.00 |
Previous close | 33.49 |
Average volume | 194.47k |
---|---|
Shares outstanding | 23.79m |
Free float | 16.16m |
P/E (TTM) | -- |
Market cap | 796.60m USD |
EPS (TTM) | -0.9647 USD |
Data delayed at least 15 minutes, as of May 09 2024 21:00 BST.
More ▼